Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone

NCT00445575 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Fibrous Dysplasia of Bone

Interventions

DRUG: risedronate
DRUG: placebo
DRUG: risedronate
DRUG: placebo

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborators

[object Object]
[object Object]
[object Object]